Cargando…
Characterization of Samples Identified as Hepatitis C Virus Genotype 1 without Subtype by Abbott RealTime HCV Genotype II Assay Using the New Abbott HCV Genotype Plus RUO Test
Hepatitis C virus (HCV) genotyping continues to be relevant for therapeutic strategies. Some samples are reported as genotype 1 (gt 1) without subtype by the Abbott RealTime HCV Genotype II (GT II) test. To characterize such samples further, the Abbott HCV Genotype Plus RUO (Plus) assay, which targe...
Autores principales: | Mokhtari, Camelia, Ebel, Anne, Reinhardt, Birgit, Merlin, Sandra, Proust, Stéphanie, Roque-Afonso, Anne-Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733213/ https://www.ncbi.nlm.nih.gov/pubmed/26582834 http://dx.doi.org/10.1128/JCM.02264-15 |
Ejemplares similares
-
Reliable resolution of ambiguous hepatitis C virus genotype 1 results with the Abbott HCV Genotype Plus RUO assay
por: Saludes, V., et al.
Publicado: (2019) -
Evaluation of the Abbott Real Time HCV genotype II assay for Hepatitis C virus genotyping
por: Sariguzel, Fatma Mutlu, et al.
Publicado: (2015) -
Analytical Sensitivity of the Abbott BinaxNOW COVID-19 Ag Card
por: Perchetti, Garrett A., et al.
Publicado: (2021) -
The performance of HCV GT plus RUO reagent in determining Hepatitis C virus genotypes in Taiwan
por: Huang, Ying-Chou, et al.
Publicado: (2021) -
Verification and Validation of SARS-CoV-2 Assay Performance on the Abbott m2000 and Alinity m Systems
por: Hirschhorn, Julie W., et al.
Publicado: (2021)